Drugs / Lidocaine (without epinephrine)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03576508 Background | Jun → Sep 2018 | osteoarthritis, knee | Centrexion Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lidocaine (without epinephrine) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03576508 ↗ |
| Route | Other | “15 mL IA injection of 2% lidocaine (without epinephrine)” NCT03576508 ↗ |